International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology Report of Basel and Three Virtual Business Meetings: Update on Blood Group Systems
Overview
Authors
Affiliations
Background And Objectives: Under the ISBT, the Working Party (WP) for Red Cell Immunogenetics and Blood Group Terminology is charged with ratifying blood group systems, antigens and alleles. This report presents the outcomes from four WP business meetings, one located in Basel in 2019 and three held as virtual meetings during the COVID-19 pandemic in 2020 and 2021.
Materials And Methods: As in previous meetings, matters pertaining to blood group antigen nomenclature were discussed. New blood group systems and antigens were approved and named according to the serologic, genetic, biochemical and cell biological evidence presented.
Results: Seven new blood group systems, KANNO (defined numerically as ISBT 037), SID (038), CTL2 (039), PEL (040), MAM (041), EMM (042) and ABCC1 (043) were ratified. Two (039 and 043) were de novo discoveries, and the remainder comprised reported antigens where the causal genes were previously unknown. A further 15 blood group antigens were added to the existing blood group systems: MNS (002), RH (004), LU (005), DI (010), SC (013), GE (020), KN (022), JMH (026) and RHAG (030).
Conclusion: The ISBT now recognizes 378 antigens, of which 345 are clustered within 43 blood group systems while 33 still have an unknown genetic basis. The ongoing discovery of new blood group systems and antigens underscores the diverse and complex biology of the red cell membrane. The WP continues to update the blood group antigen tables and the allele nomenclature tables. These can be found on the ISBT website (http://www.isbtweb.org/working-parties/red-cell-immunogenetics-and-blood-group-terminology/).
A Review of the Knops Blood Group System.
Ma X, Zhao Z, Zhang Y, Li L, Zhong J Clin Appl Thromb Hemost. 2024; 30:10760296241309638.
PMID: 39706812 PMC: 11662384. DOI: 10.1177/10760296241309638.
Hemolytic disease of the fetus and newborn-a perspective of immunohematology.
Rodrigues M, Mattos D, Almeida S, Fiegenbaum M Hematol Transfus Cell Ther. 2024; 46 Suppl 5:S246-S257.
PMID: 39242288 PMC: 11670614. DOI: 10.1016/j.htct.2024.04.122.
Wang S, Meng Z, Zhang Y, Yan Y, Li L Front Neurol. 2024; 15:1392984.
PMID: 39050130 PMC: 11266091. DOI: 10.3389/fneur.2024.1392984.
Claessen M, Yagci N, Fu K, Brandsma E, Kersten M, von Lindern M Sci Rep. 2024; 14(1):15592.
PMID: 38971841 PMC: 11227516. DOI: 10.1038/s41598-024-66440-z.
Resolution of Haplotype Ambiguities in Transfusion Settings.
Izard C, Laget L, Beley S, Bichel N, De Boisgrollier L, Picard C Int J Mol Sci. 2024; 25(11).
PMID: 38892055 PMC: 11172784. DOI: 10.3390/ijms25115868.